Q3 2024 Forian Inc Earnings Call Transcript

Nov 13, 2024 / 09:30PM GMT
Release Date Price: $2.04 (-0.04%)

Key Points

Positve
  • Forian Inc (FORA) experienced increased sales wins in both healthcare services and life sciences, indicating positive momentum.
  • The acquisition of Kyber Data Science is expected to expand Forian's addressable market and strengthen its data science and predictive analytic capabilities.
  • Kyber Data Science has a strong reputation and customer base, including some of the largest hedge funds, which could enhance Forian's market position.
  • Forian's Data Factory platform continues to aggregate and integrate diverse data sources, now including financial data through the Kyber acquisition.
  • The company maintains a strong balance sheet with $49.4 million in cash and marketable securities, providing capital for growth opportunities.
Negative
  • Forian Inc (FORA) reported a decrease in revenue to $4.7 million, down from $5.3 million year-over-year, indicating a decline in financial performance.
  • The company experienced a net loss of $0.2 million for the quarter, compared to a net income of $4.3 million in the previous year.
  • Adjusted EBITDA decreased to $0.2 million from $1.1 million year-over-year, reflecting lower profitability.
  • Revenue has been relatively flat due to macro end market factors and previous customer attrition, with no immediate breakout expected until 2025.
  • Operating loss from continuing operations remained at approximately $0.8 million, with increased costs related to information licensing and infrastructure.
Operator

Greetings, and welcome to Forian Inc. third quarter 2024 financial results conference call and webcast. (Operator Instructions). Participating today from Forian are Max Wygod, Executive Chairman and Chief Executive Officer; and Michael Vesey, Chief Financial Officer.

Before we begin, I would like to remind you that management's remarks today may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements due to a variety of important factors, including those discussed in the Risk Factors section of the company's annual report on Form 10-K filed with the SEC on March 29, 2024.

In particular, management will discuss an estimated of its full year 2024 revenue outlook as of today. Estimating financial performance accurately for future performance is difficult as it involves assumptions and internal estimates that may prove to be incorrect and is based on plans and circumstances that may change. There is, therefore, a significant risk that actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot